Welcome Video
Goals
- To learn about the latest and future directions in novel therapeutics for primary cardiac sarcomas
- To learn about how a patient traverses the health care system once diagnosed with a cardiac tumour
Objectives
- Develop an understanding of an approach to primary sarcomas from a molecular approach
- Describe the importance of MDM2 and CDk4 in the assessment and treatment of Primary cardiac tumours
- Differentiate the roles of MDM2 and checkpoint inhibitors in malignant primary cardiac tumours
- Compare the journey of a patient with a cardiac tumour in different countries
- Provide a platform for discussion for future clinical trials in cardiac sarcoma